checkAd
    Startseite > Aktien > Bolt Biotherapeutics > Nachrichten
    Bolt Biotherapeutics Aktie
    1,0340
     
    EUR
    -4,79 %
    -0,0520 EUR
    Letzter Kurs 26.04.24 Tradegate
    1,0060
     
    EUR
    2.930 STK
    Geldkurs 13:43:45
    1,0520
     
    EUR
    2.825 STK
    Briefkurs 13:43:45
    ISIN: US0977021049 · WKN: A2QNZN · SYM: 6LP · USA

    Neueste Nachrichten

    Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
    21.03.24 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
    27.02.24 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
    09.11.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
    07.11.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress
    23.10.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics to Present Data at the Society for Immunotherapy of Cancer’s 2023 Annual Meeting
    18.10.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers
    17.10.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023
    16.10.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics Receives Orphan Drug Designation for BDC-1001 for Treatment of Gastric Cancers
    28.09.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics Announces Issuance of U.S. Patent Covering Dectin-2-Targeting Agonist Antibodies, Including BDC-3042
    12.09.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics to Participate in September Investor Conferences
    05.09.23 · globenewswire · Bolt Biotherapeutics
    Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
    07.08.23 · globenewswire · Bolt Biotherapeutics